New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 28, 2012
10:30 EDTAMRNHumana posts new policy coverage for Amarin's Vascepa
Humana posted on its website a December 27, 2012 pharmacy policy coverage for Amarin's omega]3 fatty acid agent Vascepa. The insurer said Vascepa may be considered medically necessary when the following criteria are met: The member must be utilizing Vascepa for treatment of severe hypertriglyceridemia and the member must have documentation of previous treatment, intolerance, or contraindication to Lovaza and one of either Fibrate or Nicotinic acid. Humana added that Vascepa will be approved in plan year durations or as determined through clinical review. Reference Link
News For AMRN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
07:35 EDTAMRNCardiometabolic Health Congress to hold annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use